U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559292) titled 'Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes' on April 23.
Brief Summary: This pragmatic clinical trial is being conducted to test the effectiveness of AI in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 4 primary care clinics. This is an autonomous AI-based screening to detect diabetic eye disease at primary care visits.
Study Start Date: Feb. 15
Study Type: INTERVENTIONAL
Condition:
Vision Disorders
Diabetes
Intervention:
OTHER: AI
AI-based eye screening program
OTHER: Usual Practice
PCP recommends annual vision screening, a separate visit ...